These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5355567)

  • 21. [Current analysis and imposed voltage in the study of anti-arrhythmic properties of quinidine applied to frog myocardium].
    Driot P; Garnier D
    C R Acad Hebd Seances Acad Sci D; 1972 Jun; 274(25):3421-4. PubMed ID: 4626106
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative studies with beta-receptor blocking agents and quinidine].
    Saameli K
    Helv Physiol Pharmacol Acta; 1967; 25(4):CR432+. PubMed ID: 5586888
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of alkyl substitution in drugs. XIX. Synthesis and pharmacological properties of a series of 1-(diarylmethoxy)-3-(isopropylamino)-2-propanol hydrochlorides showing antiarrhythmic activity.
    De Vries J; Nauta WT; Timmerman H; van Hell G; Mulder D
    Arzneimittelforschung; 1968 Sep; 18(9):1200-3. PubMed ID: 5755937
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacological studies on the myocardial effects of O,S-dicarbethoxythiamine (DCET).
    Ueda M
    Jpn J Pharmacol; 1966 Mar; 16(1):53-62. PubMed ID: 5297506
    [No Abstract]   [Full Text] [Related]  

  • 25. The interaction between quinidine and propranolol on isolated heart muscle preparations.
    Lameijer W; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1974 May; 209(1):10-3. PubMed ID: 4416330
    [No Abstract]   [Full Text] [Related]  

  • 26. Electrophysiologic effects of 3-(p-chlorophenyl)-(2-imadazolin-2-yl-methyl)-1,2,3,4-tetrahydro-1-benzepine hydrochloride (SU-13197), a new antiarrhythmic agent.
    Watanabe Y; Dreifus LS
    J Pharmacol Exp Ther; 1968 Jan; 159(1):146-52. PubMed ID: 5643942
    [No Abstract]   [Full Text] [Related]  

  • 27. Alteration of excitability of the rabbit ventricle by quinidine, disopyramide and pronethalol.
    Deshpande SS; Mokler CM
    Arch Int Pharmacodyn Ther; 1967 Sep; 169(1):55-65. PubMed ID: 4383277
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of omission of buffers from Krebs-Ringer medium on contractility and membrane potentials of rat atria.
    Ko KC; Berman DA
    Proc West Pharmacol Soc; 1967; 10():56-60. PubMed ID: 6055505
    [No Abstract]   [Full Text] [Related]  

  • 29. Quantitative evaluation of the cardiodepressive action of halothane and some related drugs in isolated heart muscle comparison with in vivo circumstances.
    Porsius AJ; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):134-43. PubMed ID: 4757843
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of several anti-arrhythmic substances on ion currents in from atrium].
    Porotikov VI; Filippov AK; Mashkovskiĭ MD; Zaĭtseva KA
    Farmakol Toksikol; 1979; 42(2):142-7. PubMed ID: 437081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Block of NA+ and K+ currents in rat ventricular myocytes by quinacainol and quinidine.
    Pugsley MK; Walker MJ; Saint DA
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):60-5. PubMed ID: 15730436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of active antiarrhythmia substances on refractory period and contractility of guinea pig atria].
    Heeg E; Reuter N; Steiger H
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):244-5. PubMed ID: 4243341
    [No Abstract]   [Full Text] [Related]  

  • 33. [Actions of anti-arrhythmic agents on physiology of myocardial cell membrane].
    Mashiba H; Kanaya S
    Nihon Rinsho; 1974 Sep; 32(9):2829-34. PubMed ID: 4613891
    [No Abstract]   [Full Text] [Related]  

  • 34. Inotropic stimuli and systolic transmembrane calcium flow in depolarized guinea-pig atria.
    Thyrum PT
    J Pharmacol Exp Ther; 1974 Jan; 188(1):166-79. PubMed ID: 4203372
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparison of the anti-arrhythmia and local anesthetizing actions of some substances].
    Diadiura ZhA; L'vov MV
    Farmakol Toksikol; 1975; 38(2):170-3. PubMed ID: 1227882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings: The potentiation of the antiarrhythmic effects of quinidine sulfate, lidocaine and ajmaline by tween 80.
    Rohte O; Jakovljević V
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R81. PubMed ID: 4276637
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison of the dromotropic effects of disopyramide, dihydroquinidine and procainamide].
    Duchene-Marullaz P; Schaff G; Lavarenne J; Lautier F; Lapalus P
    Therapie; 1971; 26(1):89-95. PubMed ID: 5554771
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
    Carmeliet E
    Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison of the effects of quinidine, diphenylhydantoin and disopyramide on the auricular refractory period in the anesthetized dog].
    Duchêne-Marullaz P; Lapalus P; Lavarenne J; Combre A
    Arch Int Pharmacodyn Ther; 1974 Sep; 211(1):150-8. PubMed ID: 4460907
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anti-arrhythmic drugs].
    Platek H
    Wiad Lek; 1973 Apr; 26(7):623-7. PubMed ID: 4573504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.